Dissecting the VanRS signal transduction pathway with specific inhibitors

Area of Science:

• Microbiology
• Molecular Biology
• Biochemistry

Background:

• The VanRS two-component system regulates vancomycin resistance in Enterococcus faecium.
• Two-component signal transduction pathways are crucial for bacterial adaptation and virulence.
• Previous studies identified LY-266,400 as an inhibitor of a similar pathway in Pseudomonas aeruginosa.

Purpose of the Study:

• To reconstitute and characterize the VanRS two-component system in vitro.
• To investigate the inhibitory mechanism of LY-266,400 on the VanRS pathway.
• To determine the effect of LY-266,400 on vancomycin resistance gene expression.

Main Methods:

• In vitro reconstitution of the VanRS two-component system using partially purified components.
• Biochemical assays to measure VanS autophosphorylation and VanR phosphorylation.
• Analysis of transcriptional activation of the VanHAXYZ gene cluster.

Main Results:

• The VanRS system was successfully reconstituted in vitro.
• LY-266,400 inhibited the VanRS pathway by preventing VanR from accepting phosphate from VanS approximately P.
• An apparent stimulatory effect of LY-266,400 on VanS autophosphorylation was observed due to the accumulation of VanS approximately P.
• Inhibitor A acts on the second step of signal transduction, ultimately blocking vancomycin resistance gene expression.

Conclusions:

• LY-266,400 effectively inhibits the VanRS two-component signal transduction pathway.
• The mechanism of inhibition involves interference with phosphotransfer to VanR, not VanS autophosphorylation.
• This study provides a molecular basis for targeting two-component systems to combat antibiotic resistance.